Diclofenac (topical) vs Angiotensin II Receptor Blockers

Interacting Drugs
Diclofenac (topical)
vs
Angiotensin II Receptor Blockers
Security Level
Minor, Monitor Therapy
Mechanism
Angiotensin II Receptor Blockers: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Angiotensin II Receptor Blockers. The combination of these two agents may also significantly decrease glomerular filtration and renal function.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Diclofenac (topical) vs Angiotensin II Receptor Blockers


Other Interactions of Diclofenac (topical)

We are Developing Our database, More results coming soon.

Other Interactions of Angiotensin II Receptor Blockers

We are Developing Our database, More results coming soon.